Akili is developing video game-based digital medicine to improve cognitive function. The company uses features of the tech and entertainment industries to develop it's digital treatment and address inattention in children with attention deficit hyperactivity disorder.

Register for Details

For more details on financing and valuation for Akili, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Akili

Forge green plus iconForge green minus icon

What is Akili's IPO price?

Akili's IPO price is $0.345 as of 1/18/24.
Forge green plus iconForge green minus icon

What is Akili's funding to date?

Akili has raised $275.08MM to date.
Forge green plus iconForge green minus icon

When was Akili founded?

Akili was founded in 2011.

Akili Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
5/26/2021 Series D $151.68MM raised $XXX.XX $XXX.XX
5/9/2018 Series C $68.2MM raised $XXX.XX $XXX.XX
7/20/2016 Series B $42.36MM raised $XXX.XX $XXX.XX
2/19/2012 Series A-1 and A-2 $12.83MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Apr 20, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.